Table 3. Univariate analysis of b-EBV DNA and outcome variables (DFS, OS).
EBV DNAa | DFS(median) | P valueb | OS(median) | P valueb |
---|---|---|---|---|
4 Groups | ||||
UQ | 13 | 13 | ||
Neg | 62 | 0.0001 | 62 | 0.0001 |
Q | 27 | 31 | ||
Q+ | 33.5 | 37.5 | ||
3 Groups | ||||
UQ, Q | 23 | 26 | ||
Q+ | 33.5 | 0.0001 | 37.5 | 0.0002 |
Neg | 62 | 62 |
a EBV DNA was stratified into 4 and 3 groups: Neg, Negative (EBV DNA = 0); UQ, Positive but UnQuantifiable (0 < EBV DNA < 102 copies/mL); Q, Positive and quantifiable (102 ≤ EBV DNA ≤ 15 × 102 copies/mL); Q+, Strongly positive and quantifiable (EBV DNA > 15 × 102 copies/mL).
b The categorical variables were assessed using non-parametric Kruskal Wallis ANOVA. Statistically significant P values (P<0.05) are highlighted.